Overactive Bladder
Current management and future perspectives of overactive bladder (OAB) pharmacotherapy - Abstract
December 22, 2011
Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder - Abstract
December 21, 2011
Behavioral versus drug treatment for overactive bladder in men: The Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial - Abstract
December 20, 2011
Characteristics and impact of interrupted sleep in women with overactive bladder - Abstract
December 12, 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
December 9, 2011
Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist - Abstract
December 6, 2011
Korean version of the overactive bladder symptom score questionnaire: Translation and linguistic validation - Abstract
November 29, 2011
The impact of overactive bladder on health-related quality of life, sexual life and psychological health in Korea - Abstract
November 28, 2011
Commonly used antihypertensives and lower urinary tract symptoms: Results from the Boston Area Community Health (BACH) Survey - Abstract
November 22, 2011
Anticholinergics for overactive bladder therapy: Central nervous system effects - Abstract
November 21, 2011
Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study - Abstract
November 17, 2011